Dermcidin has been identified as a biomarker for Alzheimer’s disease (AD) [29], asthma [30], acne vulgaris [31,32], severe obstructive sleep apnea [33], and facioscapulohumeral muscular dystrophy [34]. Here, DCD is linked to acne.